Literature DB >> 8643555

Immunotargeting of antioxidant enzyme to the pulmonary endothelium.

V R Muzykantov1, E N Atochina, H Ischiropoulos, S M Danilov, A B Fisher.   

Abstract

Oxidative injury to the pulmonary endothelium has pathological significance for a spectrum of diseases. Administration of antioxidant enzymes, superoxide dismutase (SOD) and catalase (Cat), has been proposed as a method to protect endothelium. However, neither these enzymes nor their derivatives possess specific affinity to endothelium and do not accumulate in the lung. Previously we have described a monoclonal antibody to angiotensin-converting enzyme (ACE) that accumulates selectively in the lung after systemic injection in rats, hamsters, cats, monkeys, and humans. In the present work we describe a system for selective intrapulmonary delivery of CuZn-SOD and Cat conjugated with biotinylated anti-ACE antibody mAb 9B9 (b-mAb 9B9) by a streptavidin (SA)-biotin bridge. Both enzymes biotinylated with biotin ester at biotin/enzyme ratio 20 retain enzymatic activity and bind SA without loss of activity. We have constructed tri-molecular heteropolymer complexes consisting of b-mAb 9B9, SA, and biotinylated SOD or biotinylated Cat and have studied biodistribution and pulmonary uptake of these complexes in the rat after i.v. injection. Biodistribution of biotinylated enzymes was similar to that of nonmodified enzymes. Binding of SA markedly prolonged lifetime of biotinylated enzymes in the circulation. In contrast to enzymes conjugated with nonspecific IgG, other enzyme derivatives, and nonmodified enzymes, biotinylated enzymes conjugated with b-mAb 9B9 accumulated specifically in the rat lung (9% of injected SOD/g of lung tissue and 7.5% of injected Cat/g of lung tissue). Pulmonary uptake of nonmodified enzymes or derivatives with nonspecific IgG did not exceed 0.5% of injected dose/g. Both SOD and Cat conjugated with b-mAb 9B9 were retained in the rat lung for at least several hours. Trichloracetic acid-precipitable radiolabeled Cat was associated with microsomal and plasma membrane fractions of the lung tissue homogenate. Thus, modification of antioxidant enzymes with biotin and SA-mediated conjugation with b-mAb 9B9 prolongs the circulation of enzymes resulting in selective accumulation in the lung and intracellular delivery of enzymes to the pulmonary endothelium. These results provide the background for an approach to provide protection of pulmonary endothelium against oxidative insults.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643555      PMCID: PMC39224          DOI: 10.1073/pnas.93.11.5213

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation.

Authors:  S Danilov; E Atochina; H Hiemisch; T Churak-ova; A Moldobayeva; I Sakharov; G Deichman; U Ryan; V R Muzykantov
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

2.  The angiotensin I-converting enzyme.

Authors:  E G Erdös; R A Skidgel
Journal:  Lab Invest       Date:  1987-04       Impact factor: 5.662

3.  Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall.

Authors:  V N Smirnov; S P Domogatsky; V V Dolgov; V B Hvatov; A L Klibanov; V E Koteliansky; V R Muzykantov; V S Repin; G P Samokhin; B V Shekhonin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Investigations of avidin and biotin for imaging applications.

Authors:  D J Hnatowich; F Virzi; M Rusckowski
Journal:  J Nucl Med       Date:  1987-08       Impact factor: 10.057

5.  Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot.

Authors:  V R Muzykantov; D V Sakharov; M D Smirnov; G P Samokhin; V N Smirnov
Journal:  Biochim Biophys Acta       Date:  1986-11-19

6.  Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice.

Authors:  J Schalkwijk; W B van den Berg; L B van de Putte; L A Joosten; L van den Bersselaar
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.

Authors:  J F Turrens; J D Crapo; B A Freeman
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Proteases and oxidants in experimental pulmonary inflammatory injury.

Authors:  I U Schraufstätter; S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Immunotargeting of streptavidin to the pulmonary endothelium.

Authors:  V R Muzykantov; E N Atochina; V Gavriljuk; S M Danilov; A B Fisher
Journal:  J Nucl Med       Date:  1994-08       Impact factor: 10.057

Review 10.  Free radicals in diabetic endothelial cell dysfunction.

Authors:  B Tesfamariam
Journal:  Free Radic Biol Med       Date:  1994-03       Impact factor: 7.376

View more
  28 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

2.  Endothelial targeting of antibody-decorated polymeric filomicelles.

Authors:  Vladimir V Shuvaev; Marc A Ilies; Eric Simone; Sergei Zaitsev; Younghoon Kim; Shenshen Cai; Abdullah Mahmud; Thomas Dziubla; Silvia Muro; Dennis E Discher; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2011-08-23       Impact factor: 15.881

Review 3.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

4.  Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

Authors:  Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Arnaud Scherpereel; Eric Simone; Evguenia Arguiri; Samira Tliba; Jeremy Pick; Stephen Kennel; Steven M Albelda; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2007-01-08       Impact factor: 9.776

5.  Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.

Authors:  Vladimir V Shuvaev; Samira Tliba; Jeremy Pick; Evguenia Arguiri; Melpo Christofidou-Solomidou; Steven M Albelda; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2010-10-31       Impact factor: 9.776

Review 6.  Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.

Authors:  Patrick M Glassman; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2019-03-05       Impact factor: 4.030

7.  Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier.

Authors:  Oscar A Marcos-Contreras; Colin F Greineder; Raisa Yu Kiseleva; Hamideh Parhiz; Landis R Walsh; Viviana Zuluaga-Ramirez; Jacob W Myerson; Elizabeth D Hood; Carlos H Villa; Istvan Tombacz; Norbert Pardi; Alecia Seliga; Barbara L Mui; Ying K Tam; Patrick M Glassman; Vladimir V Shuvaev; Jia Nong; Jacob S Brenner; Makan Khoshnejad; Tom Madden; Drew Weissmann; Yuri Persidsky; Vladimir R Muzykantov
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-31       Impact factor: 11.205

8.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

Review 9.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

Review 10.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.